Llwytho...
Management of infusion reactions associated with cetuximab treatment: A case report
Cetuximab is a drug targeting the epidermal growth factor receptor, which is indicated for the treatment of unresectable advanced or recurrent head and neck or colorectal cancer. Cetuximab also enhances the cytotoxic effects of radiation in squamous cell carcinoma. The severity of infusion reactions...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Clin Oncol |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
D.A. Spandidos
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451859/ https://ncbi.nlm.nih.gov/pubmed/28588776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1242 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|